These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9199349)

  • 41. Block of granulocytic differentiation of 32Dcl3 cells by AML1/ETO(MTG8) but not by highly expressed Bcl-2.
    Kohzaki H; Ito K; Huang G; Wee HJ; Murakami Y; Ito Y
    Oncogene; 1999 Jul; 18(28):4055-62. PubMed ID: 10435586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of AML1 renders a T hybridoma resistant to T cell receptor-mediated apoptosis.
    Fujii M; Hayashi K; Niki M; Chiba N; Meguro K; Endo K; Kameoka J; Ito S; Abe K; Watanabe T; Satake M
    Oncogene; 1998 Oct; 17(14):1813-20. PubMed ID: 9778047
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1.
    Kitabayashi I; Ida K; Morohoshi F; Yokoyama A; Mitsuhashi N; Shimizu K; Nomura N; Hayashi Y; Ohki M
    Mol Cell Biol; 1998 Feb; 18(2):846-58. PubMed ID: 9447981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alternative splicing removes an Ets interaction domain from Lozenge during Drosophila eye development.
    Jackson Behan K; Fair J; Singh S; Bogwitz M; Perry T; Grubor V; Cunningham F; Nichols CD; Cheung TL; Batterham P; Pollock JA
    Dev Genes Evol; 2005 Aug; 215(8):423-35. PubMed ID: 15868204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. AML1 is expressed in skeletal muscle and is regulated by innervation.
    Zhu X; Yeadon JE; Burden SJ
    Mol Cell Biol; 1994 Dec; 14(12):8051-7. PubMed ID: 7969143
    [TBL] [Abstract][Full Text] [Related]  

  • 46. AML1-ETO decreases ETO-2 (MTG16) interactions with nuclear receptor corepressor, an effect that impairs granulocyte differentiation.
    Ibañez V; Sharma A; Buonamici S; Verma A; Kalakonda S; Wang J; Kadkol S; Saunthararajah Y
    Cancer Res; 2004 Jul; 64(13):4547-54. PubMed ID: 15231665
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1).
    Zhang DE; Fujioka K; Hetherington CJ; Shapiro LH; Chen HM; Look AT; Tenen DG
    Mol Cell Biol; 1994 Dec; 14(12):8085-95. PubMed ID: 7969146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of the region of mi transcription factor which is responsible for the synergy with PEBP2/CBF.
    Morii E; Ogihara H; Kanno T; Kim DK; Nomura S; Ito Y; Kitamura Y
    Biochem Biophys Res Commun; 1999 Jul; 261(1):53-7. PubMed ID: 10405322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide.
    Sakakura C; Yamaguchi-Iwai Y; Satake M; Bae SC; Takahashi A; Ogawa E; Hagiwara A; Takahashi T; Murakami A; Makino K
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11723-7. PubMed ID: 7972130
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TLE, the human homolog of groucho, interacts with AML1 and acts as a repressor of AML1-induced transactivation.
    Imai Y; Kurokawa M; Tanaka K; Friedman AD; Ogawa S; Mitani K; Yazaki Y; Hirai H
    Biochem Biophys Res Commun; 1998 Nov; 252(3):582-9. PubMed ID: 9837750
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of two transcripts of AML1/ETO-fused gene in t(8;21) leukemic cells and expression of wild-type ETO gene in hematopoietic cells.
    Era T; Asou N; Kunisada T; Yamasaki H; Asou H; Kamada N; Nishikawa S; Yamaguchi K; Takatsuki K
    Genes Chromosomes Cancer; 1995 May; 13(1):25-33. PubMed ID: 7541640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties.
    Zent CS; Mathieu C; Claxton DF; Zhang DE; Tenen DG; Rowley JD; Nucifora G
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1044-8. PubMed ID: 8577711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of genes under the downstream control of the t(8;21) fusion protein AML1-MTG8: overexpression of the TIS11b (ERF-1, cMG1) gene induces myeloid cell proliferation in response to G-CSF.
    Shimada H; Ichikawa H; Nakamura S; Katsu R; Iwasa M; Kitabayashi I; Ohki M
    Blood; 2000 Jul; 96(2):655-63. PubMed ID: 10887131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation mechanisms for the heterodimeric transcription factor, PEBP2/CBF.
    Bae SC; Ito Y
    Histol Histopathol; 1999 Oct; 14(4):1213-21. PubMed ID: 10506937
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionarily conserved, putative transcription factor.
    Erickson PF; Robinson M; Owens G; Drabkin HA
    Cancer Res; 1994 Apr; 54(7):1782-6. PubMed ID: 8137293
    [TBL] [Abstract][Full Text] [Related]  

  • 56. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis.
    Okuda T; van Deursen J; Hiebert SW; Grosveld G; Downing JR
    Cell; 1996 Jan; 84(2):321-30. PubMed ID: 8565077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New mechanisms of AML1 gene alteration in hematological malignancies.
    Roumier C; Fenaux P; Lafage M; Imbert M; Eclache V; Preudhomme C
    Leukemia; 2003 Jan; 17(1):9-16. PubMed ID: 12529654
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1.
    Nucifora G; Begy CR; Erickson P; Drabkin HA; Rowley JD
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7784-8. PubMed ID: 8395054
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias.
    Osato M; Asou N; Abdalla E; Hoshino K; Yamasaki H; Okubo T; Suzushima H; Takatsuki K; Kanno T; Shigesada K; Ito Y
    Blood; 1999 Mar; 93(6):1817-24. PubMed ID: 10068652
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21.
    Preudhomme C; Warot-Loze D; Roumier C; Grardel-Duflos N; Garand R; Lai JL; Dastugue N; Macintyre E; Denis C; Bauters F; Kerckaert JP; Cosson A; Fenaux P
    Blood; 2000 Oct; 96(8):2862-9. PubMed ID: 11023523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.